Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Genetic Technologies Ltd

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType to Enter Canadian and New Zealand Markets
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Expands Operational Capacity in North America
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType and Humanise Health host “Know Your Risk” Event
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Appendix 4C & Quarterly Business Update – March 2024
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Announces $2 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG to pilot GeneType in Breast Screen centers across the U.S.
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG Global Collaborations and Innovation Update
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG to launch U.S. Customer Digital Media Sales Campaign
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Launching our most comprehensive test and expanding into new global markets
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.